Our news

1678 news items

Research

Gene therapy on hold in Danon disease

On 10/07/2025

Despite encouraging results from a phase I trial of the RP-A501 gene therapy for cardiomyopathy in Danon disease, the phase II trial which had started…

Research

Tolerance of efgartimod in myasthenia gravis

On 25/06/2025

Chinese researchers have studied the adverse reactions observed when efgartigimod, a new-generation immunosuppressant used, among other indications, in refractory autoimmune myasthenia, is administered: their work…